American Journal of Clinical Dermatology

Papers
(The H4-Index of American Journal of Clinical Dermatology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Blue Nail Discoloration: Literature Review and Diagnostic Algorithms118
Tralokinumab for the Treatment of Atopic Dermatitis114
Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases106
Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study103
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions87
Characterization of Clinicopathological Features and Autoantibody Profiles in Patients with Cutaneous Lupus Erythematous: A Single-Center Retrospective Study82
Individualized Neoantigen-Directed Melanoma Therapy79
Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma78
Meat Allergy: A Ticking Time Bomb72
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”71
Classification and Treatment of Angioedema without Wheals: A Spanish Delphi Consensus66
Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”66
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada65
Eczematous Drug Eruptions54
What’s New in Topicals for Atopic Dermatitis?54
Diagnosis of Generalized Pustular Psoriasis51
Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review50
Acknowledgment to Referees48
Non-invasive Skin Imaging in Cutaneous Lymphomas46
Comment on “Efficacy and Safety of Brodalumab, an Anti‑interleukin‑17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16‑Week Results of a Randomized Clinical Trial”40
Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study40
The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review40
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview39
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review38
Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments35
Frontal Fibrosing Alopecia: An Update35
Erythema Nodosum: A Practical Approach and Diagnostic Algorithm35
Image-Based Artificial Intelligence in Psoriasis Assessment: The Beginning of a New Diagnostic Era?35
Prognostic Biomarkers in Evolving Melanoma Immunotherapy35
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative33
Clinical Disease Measures in Generalized Pustular Psoriasis33
The Current State of Systemic Therapy of Metastatic Uveal Melanoma33
0.056066989898682